Recruiting Huntingtons Disease Studies in Savannah
Study to Evaluate NRCT-101SR in Pediatric Subjects with ADHD
To evaluate the efficacy and safety of NRCT-101SR compared to placebo in subjects 13-17 years of age with ADHD...
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
A combination therapy of NRCT-101 with NRCT-202 is being developed for patients with ADHD....
About Huntingtons Disease Clinical Trials in Savannah
Huntington's disease is an inherited condition that causes progressive degeneration of nerve cells in the brain, affecting movement, cognition, and behavior. It is caused by a mutation in the HTT gene. Current treatments manage symptoms, while gene-silencing therapies are being studied.
There are currently 2 huntingtons disease clinical trials recruiting participants in Savannah, GEORGIA. These studies are seeking a combined 220 participants. Research is being sponsored by Neurocentria, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Huntingtons Disease Clinical Trials in Savannah — FAQ
Are there huntingtons disease clinical trials in Savannah?
Yes, there are 2 huntingtons disease clinical trials currently recruiting in Savannah, GEORGIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Savannah?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Savannah research site will contact you about next steps.
Are clinical trials in Savannah free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Savannah studies also compensate for your time and travel.
What huntingtons disease treatments are being tested?
The 2 active trials in Savannah are testing new therapies including novel drugs, biologics, and treatment approaches for huntingtons disease.
Data updated March 2, 2026 from ClinicalTrials.gov